Home >> WEBINARS >> Fecal matters: Molecular GI testing

Fecal matters: Molecular GI testing

Print Friendly, PDF & Email

Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters: Daniel D. Rhoads, MD and Jose (Alex) Alexander, MD, D(ABMM), SM, MB(ASCP)

  • Listen to national thought leaders discuss molecular GI testing
  • Understand the application of new guidelines
  • Assess the impact of molecular GI testing
  • Learn tips for implementation and justification

Originally broadcast: April 25, 2018

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Luminex.

Please note: We currently do not offer education credits for CAP TODAY webinars.


Check Also

Molecular lung cancer testing: from guideline to practice

August 2018—Testing turnaround times can affect whether non-small cell lung cancer patients receive an EGFR or ALK tyrosine kinase inhibitor when indicated. At disease progression on an EGFR TKI, integrating circulating tumor DNA and tissue-based testing may lessen some of the limitations of each form of testing.